http://www.fpnotebook.com/
Midodrine
- Indications
- Mechanism
- Alpha agonist: constricts arterioles and veins
- Increases peripheral resistance
- Efficacy
- Study: n=162, PCT
- Significantly improved standing BP and symptoms
- Reference
- Study: n=162, PCT
- Adverse Effects
- Pilomotor reactions
- Urinary urgency and retention
- Supine Hypertension
- Dosing
- Dose: 10 mg PO tid
Midodrine (C0026078) | |
|---|---|
| Definition (MSH) | An ethanolamine derivative that is an adrenergic alpha agonist. It is used as a vasoconstrictor agent in the treatment of hypotension. |
| Definition (NCI) | A direct-acting prodrug and sympathomimetic agent with antihypotensive properties. Midodrine is converted to its active metabolite, desglymidodrine by deglycination reaction. Desglymidodrine selectively binds to and activates alpha-1-adrenergic receptors of the arteriolar and venous vasculature. This causes smooth muscle contraction and leads to an elevation of blood pressure. Desglymidodrine diffuses poorly across the blood-brain barrier, and is therefore not associated with effects on the central nervous system (CNS). |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D008879 |
| English | Midodrin, Midodrine, MIDODRINE PREPARATION |
| Spanish | midodrina |
| Parent Concepts | Ethanolamines (C0014983), Adrenergic alpha-Agonists (C0001640), [CV900] CARDIOVASCULAR AGENTS, OTHER (C0991601), Sympathomimetics (C0039052) |
| Sources | MSH, NCI, NDFRT, RXNORM, SCTSPA, SNOMEDCT, USPMG, VANDF Derived from the NIH UMLS (Unified Medical Language System) |
